Navigation Links
VolitionRx-led Consortium Awarded euro 780 000 ($1M approx.) Eurostars Grant
Date:9/3/2013

NAMUR, Belgium, Sept. 3, 2013 /PRNewswire/ -- VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, is lead partner of a consortium in a project valued at €779,493 (approx. US$1M) under the EUREKA Eurostars scheme. The project aims to develop new applications of the Nucleosomics biomarker technology in inflammatory disease. The research will build on VolitionRx's ongoing cancer diagnostic research program.

VolitionRx's contribution to the project is to develop novel NuQ® biomarkers for immune response. VolitionRx will use its proprietary Nucleosomics® platform for biomarker development exploiting UK-based Alcyomics' proprietary ex-vivo Skimmune™ model.

The Eurostars Programme is a European innovation program managed by EUREKA. It is the first program dedicated to supporting research-based small- and medium-sized companies (SMEs) from across Europe. To be eligible for the grant, companies must form a consortium of at least two companies from different European countries, with the aim of developing a civilian-purposed new product, process or service.

"The Eurostars scheme is a prestigious European program designed to support SMEs like VolitionRx, and to encourage cross-border research and development collaboration," says Mark Eccleston, VolitionRx's External Collaborations Manager. "We are looking forward to working with our partners to develop novel applications for our Nucleosomics technology, while complementing our ongoing research in cancer diagnostics."

Under the grant, VolitionRx will be reimbursed with 80% of the costs associated with its share of the joint project  - €420,000 ($0.56M approx.) over two years.

About VolitionRx
VolitionRx is a life
'/>"/>

SOURCE VolitionRx Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Elsevier Announces its Collaboration with Hungarian National Consortium
2. Pfizer, GSK, and Siemens Form R&D Consortium With A*STARs Institute of Chemical & Engineering Sciences
3. Herbal Quality Consortium Publishes Major Article on Black Cohosh Adulteration
4. Elekta and Philips Gain MD Anderson Cancer Center as Collaborator in Research Consortium on MRI-Guided Radiation Therapy
5. Some Bilberry Fruit Extracts Adulterated, says Nonprofit Research Consortium
6. Tel Aviv University to spearhead groundbreaking nanotechnology consortium
7. JCVI Researchers, as Part of NIH Human Microbiome Project Consortium, Publish Papers Detailing the Variety and Abundance of Microbes Living on and in the Human Body
8. Pharmaceutical Consortium Selects BioFortis Software to Manage Collaborative Clinical Data and Biobanking Activities
9. Nonprofit Consortium Publishes Review of Skullcap Adulteration
10. Fumio Hirakawa has been awarded with the notable Golden A' Design Award
11. Curemark Awarded New Patent For Treatment Of Drug And Alcohol Addiction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Global Stem Cells Group has ... 2015 April 27 - 29, 2015 in Boston. This ... areas of stem cell research including applications, biology, medicine, ... medicine. , The conference will address recent developments ... research in stem cell therapies, regenerative medicine, tissue engineering, ...
(Date:4/16/2015)... OSAKA, Japan , April 16, 2015 ... of Kyoto University and Takeda Pharmaceutical Company Limited ... to develop clinical applications of induced pluripotent stem ... mellitus, neurological disorders and cancer immunotherapy. The "Takeda-CiRA ... designed to expedite multiple research projects for drug ...
(Date:4/16/2015)... CA (PRWEB) April 16, 2015 ... the Buzz of BIO Contest for the ... Organization (BIO), the 2015 BIO International Convention will take ... Philadelphia, Pennsylvania. During the Buzz of BIO contest, industry ... to see present at the conference. The community voting ...
(Date:4/16/2015)... April 16, 2015 OncoTAb, ... Charlotte (UNC Charlotte) spin-out company, announced today the ... Ph.D., M.D., as Chief Operating Officer (COO). Cooper ... experience in developing clinical diagnostic and biotechnology platforms ... disease. , Cooper’s extensive career transcends the field ...
Breaking Biology Technology:Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015 2Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015 3CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 2CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 3Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 2Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 3OncoTAb Names Dr. David L. Cooper as COO 2
... July 25, 2011 MiMedx Group, Inc.  (OTCBB: MDXG), ... regenerative biomaterials and bioimplants processed from human amniotic membrane, ... six months ended June 30, 2011. The ... an 85% percent increase over first quarter of 2011 ...
... ERT (NASDAQ: ERT ) announced today that it ... Monday, August 1, after the market closes.  After the release, ... ET that day. For the conference call, ... States or 1-412-858-4600 when calling internationally. There will be a ...
... SHELTON, Conn., July 22, 2011 Modern Plastics, one ... stock shapes and medical-grade plastics, has moved from ... new address is 88 Long Hill Cross Road, Shelton, ... features an advanced environmentally controlled clean room for storage ...
Cached Biology Technology:MiMedx Group Announces Second Quarter 2011 Results 2MiMedx Group Announces Second Quarter 2011 Results 3MiMedx Group Announces Second Quarter 2011 Results 4MiMedx Group Announces Second Quarter 2011 Results 5MiMedx Group Announces Second Quarter 2011 Results 6MiMedx Group Announces Second Quarter 2011 Results 7MiMedx Group Announces Second Quarter 2011 Results 8MiMedx Group Announces Second Quarter 2011 Results 9MiMedx Group Announces Second Quarter 2011 Results 10ERT Reports Second Quarter 2011 Operating Results on August 1, 2011 2
(Date:4/6/2015)... , Apr. 6, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... provisional patent 62/143028 for MINIATURE, MULTI-PURPOSE ... TRANSFER  NXT-ID introduces a new revolutionary ... patent surrounds the use of miniature antenna modules ...
(Date:4/1/2015)... 1, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces the second ... is underway to early access pre-order customers. ... at retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, ... was accepted at all outlets and very easy to ...
(Date:3/26/2015)... 26, 2015 The Granite Club, ... and athletic club, today announced it has implemented a ... of movement for members and staff, while restricting access ... process, we selected FST,s IMID Access system because it ... our members and staff, in addition to unparalleled security," ...
Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
... bioMETRX Inc., (OTC,Bulletin Board: BMRX), today announced ... agreement with EZ Print, LLC for the advanced ... purchase,agreement., EZ Print, LLC will invest considerable ... the enterprise document production,business. Currently the technology branded ...
... largest field trial of its kind in the United ... Miscanthus x giganteus outperforms current biofuels sources by ... production in the U.S. could significantly reduce the acreage ... the researchers report. The new findings, from researchers ...
... (CLIC), a group of researchers from 10 academic and ... by physicians at Case Western Reserve University School of ... grant from the National Institutes of Health (NIH) to ... deficiency that causes AIDS. The grant will fund four ...
Cached Biology News:bioMETRX, Inc. Completes Exclusive Licensing Agreement With EZ Print, LLC 2bioMETRX, Inc. Completes Exclusive Licensing Agreement With EZ Print, LLC 3Miscanthus can meet US biofuels goal using less land than corn or switchgrass 2Miscanthus can meet US biofuels goal using less land than corn or switchgrass 3Case Western Reserve University School of Medicine researchers receive $10.8 million 2
For removal of the zona pellucida. Sterile, Mouse Embryo tested...
Request Info...
Imject Freund's Complete Adjuvant (FCA)...
... the secretion of cytoplasmic granules, is ... response of leukocytes (e.g. basophils, neutrophils, ... to histamine, these secretory granules contain ... chemokines, and many proteases (Hallgren, 2001). ...
Biology Products: